A Clinical Trial of P134 Cells in Recurrent Glioblastoma

NCT07318818 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma IDH Wildtype

Interventions

BIOLOGICAL: P134 cell injection

Sponsor

Tasly Pharmaceutical Group Co., Ltd